fatty liver semaglutide India has approved Wegovy (semaglutide 2.4 mg) for treating MASH (metabolic dysfunction-associated steatohepatitis)—a serious form of disease that can silently progress to liver damage if left untreated. MASH develops when Semaglutide improves fatty liver disease
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




























